LABORIE Medical Technologies Inc.
https://www.laborie.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From LABORIE Medical Technologies Inc.
Tech Transfer Roundup: Tiba And CEPI Strategize Together On ‘Disease X’
Immix collaborates with Israeli research institutions on BCMA-targeted CAR-T therapy. NeoImmuneTech/NIAID alliance could pave way for “animal rule” approval in acute radiation syndrome.
M&A Analysis – Deals March On In Big Month For Boston Scientific
Medtech Insight recorded 17 merger or acquisition deals in March, a rise from the nine deals recorded last month and in the same period last year. It was a busy month for Boston Scientific, which racked up two acquisitions, paying $460m for urology device maker NxThera and an undisclosed price for endoscopy firm EMcision.
Laborie To Buy Cogentix For $239m
The deal adds Cogentix' Urgent PC neuromodulation system for urinary incontinence, PrimeSight cystoscopy system, and Macroplastique soft-tissue bulking agent to treat female stress urinary incontinence to Laborie's range of urology and gynecology products.
M&A Analysis: No Spring For March Mergers
M&A deal activity waned in March, with a total of 9 deals completed in the month, down from 12 in February and 17 in March 2016. This third month brought the total number of deals for Q1 2017 to 33, a significant year-on-year decline compared to 51 in the first quarter of 2016.
Company Information
- Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
- Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
-
- Camden Merger Sub, Inc.
- Cogentix Medical, Inc.
- Investor AB
- LM US Parent, Inc.
- Patricia Industries
- Pelvalon, Inc.
- Clinical Innovations LLC
- GI Supply
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice